U.S. Markets close in 3 hrs 13 mins

Aeolus Pharmaceuticals, Inc. (AOLS)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.075-0.009 (-10.926%)
As of 12:28PM EDT. Market open.
People also watch
AMARCCELPPMDMCETBMSN
Full screen
Previous Close0.084
Open0.078
Bid0.000 x
Ask0.000 x
Day's Range0.075 - 0.082
52 Week Range0.050 - 0.270
Volume72,400
Avg. Volume43,498
Market Cap11.41M
Beta2.17
PE Ratio (TTM)-2.88
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Aeolus Pharmaceuticals, Inc. :AOLS-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017
    Capital Cube4 months ago

    Aeolus Pharmaceuticals, Inc. :AOLS-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis Aeolus Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Aeolus Pharmaceuticals, Inc. – Cleveland BioLabs, Inc., Amgen Inc., Fate Therapeutics, Inc., Albany Molecular Research, Inc., CytRx Corporation, Catalyst Biosciences, Inc. and Ionis Pharmaceuticals, Inc. (CBLI-US, AMGN-US, FATE-US, ... Read more (Read more...)

  • Aeolus Pharmaceuticals, Inc. :AOLS-US: Earnings Analysis: Q4, 2016 By the Numbers : January 5, 2017
    Capital Cube7 months ago

    Aeolus Pharmaceuticals, Inc. :AOLS-US: Earnings Analysis: Q4, 2016 By the Numbers : January 5, 2017

    Categories: Yahoo Finance Get free summary analysis Aeolus Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2016. Highlights Summary numbers: Revenues of USD 0.55 million, Net Earnings of USD -1.02 million. Change in operating cash flow of 54.54% compared to same period last year is about the same as change in earnings, likely no significant ... Read more (Read more...)

  • Aeolus Pharmaceuticals, Inc. :AOLS-US: Earnings Analysis: Q3, 2016 By the Numbers : August 18, 2016
    Capital Cube11 months ago

    Aeolus Pharmaceuticals, Inc. :AOLS-US: Earnings Analysis: Q3, 2016 By the Numbers : August 18, 2016

    Categories: Yahoo Finance Get free summary analysis Aeolus Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Aeolus Pharmaceuticals, Inc. – Cleveland BioLabs, Inc., MediciNova, Inc., Amgen Inc., Fate Therapeutics, Inc., Albany Molecular Research, Inc., CytRx Corporation, ProPhase Labs, Inc. and Omeros Corporation (CBLI-US, MNOV-US, ... Read more (Read more...)